KIB has received grants to his institution from AstraZeneca for this study and for lectures and consulting from Novo Nordisk, Sanofi, Lilly, Boehringer Ingelheim and Merck Sharp & Dohme. JB holds a full‐time position at AstraZeneca as an epidemiologist. AB acknowledges research support from NIHR, BMA, UKRI, HDR UK, EU and AstraZeneca. DJK has received research grant support from LG Life Sciences, Handok, Boehringer Ingelheim, and AstraZeneca; and has received speaker fees from Novo Nordisk, Novartis Korea, Boehringer Ingelheim, Lilly Korea, Handok, MSD, Hanmi and AstraZeneca. AN has received honoraria from MSD, Astra Zeneca, Eli Lilly, Boehringer Ingelheim and Novo Nordisk. JWE has received honoraria or research grants from AstraZeneca, NovoNordisk, Bayer, Sanofi and MSD. MT is employed by an independent statistical consultant company, Statisticon AB, Uppsala, Sweden, of which AstraZeneca Nordic‐Baltic is a client. SO is a full‐time employee of AstraZeneca. KHH has received research grant support from LG Life Sciences, Handok, Boehringer Ingelheim and AstraZeneca. NK is an employee of Wissenschaftliches Institut für Gesundheitsökonomie und Gesundheitssystemforschung and conducted work on behalf of Kantar Health. JBM, RZ and TY are full‐time employees of AstraZeneca. IK received grants from Astellas Pharma Inc., Boehringer Ingelheim Japan, Kowa Pharmaceutical Co. Ltd, Daiichi Sankyo Company Limited., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Ltd, Sumitomo Dainippon Pharma Co., Ltd, Pfizer Japan Inc., Takeda Pharmaceutical Company Limited., Toa Eiyo Ltd, Honorarium: Astellas Pharma Inc., Boehringer Ingelheim Japan, Kowa Pharmaceutical Co. Ltd, Daiichi Sankyo Company Limited., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Ltd, Sumitomo Dainippon Pharma Co., Ltd, Pfizer Japan Inc., Takeda Pharmaceutical Company Limited., Toa Eiyo Ltd. TK received grants from Asahi Mutual Life Insurance Co., Boehringer Ingelheim Japan, Daiichi Sankyo Company Limited, Kowa Pharmaceutical Co. Ltd, Mitsubishi Tanabe Pharma Corporation, MSD K.K., Novo Nordisk Pharma Ltd, Sanofi K.K., Takeda Pharmaceutical Company Limited. Lecture/other fees: AstraZeneca K.K., Astellas Pharma Inc., Boehringer Ingelheim Japan, Daiichi Sankyo Company Limited., Eli Lilly Japan K.K., Kowa Pharmaceutical Co. Ltd, Kyowa Hakko Kirin Co., Ltd, Mitsubishi Tanabe Pharma Corporation, MSD K.K., Ono Pharmaceutical Company, Ltd, Sanofi K.K., Sumitomo Dainippon Pharma Co., Ltd, Sanwa Kagaku Kenkyusho Co. Ltd, Taisho Pharmaceutical Co., Ltd and Takeda Pharmaceutical Company Limited.
PubMed
